摘要
目的:探讨苏子降气汤加减治疗慢阻肺急性加重期的临床疗效。方法:采取随机抽样的方法,选取2015年5月-2017年5月期间到我院接受诊治的76例急性加重期慢阻肺患者当作研究对象。应用随机数字表法,将76例慢阻肺急性加重期患者分为观察组、对照组,各38例。对照组采取常规西药治疗方案,包括持续吸氧、解除支气管痉挛、补充热量、给予祛痰药物、机械通气、抗生素治疗等。观察组采取苏子降气汤加减治疗方案,观察并对比分析两组的临床疗效、生命体征变化情况及血气分析、炎性指标变化情况。结果:治疗1个疗程后,观察组的总有效率为94.74%(36/38),明显高于对照组的76.32%(29/38),差异有统计学意义(P<0.05);治疗前,两组的各生命体征及血气分析、炎性指标比较,差异不明显、无统计学意义(P>0.05);治疗后,两组的各生命体征及血气分析、炎性指标明显改善,且观察组的改善程度明显优于对照组,差异有统计学意义(P<0.05)。结论:相比较于单纯西药治疗,苏子降气汤加减治疗慢阻肺急性加重期疗效确切,值得推广应用。
Objective: To investigate the clinical efficacy of the Suzi Jiangqi decoction(苏子降气汤) on acute exacerbation of chronic obstructive pulmonary disease. Methods: 76 cases were randomly divided into the observation group and control group, each of 38 cases. The control group received routine western medicine, including oxygen, relieve bronchial spasm, replenish the heat, medicine, mechanical ventilation, antibiotic therapy. The observation group adopted the Suzi Jiangqi decoction. Results: After 1 courses, the total efficiency was 94.74%(36/38) in the observation group, significantly higher than 76.32%(29/38) in the control group(P〈0.05). After the treatment, the vital signs and blood gas analysis in 2 groups, inflammatory index were significantly improved, and those in the observation group were better(P〈0.05). Conclusion: The Suzi Jiangqi decoction on acute exacerbation of chronic obstructive pulmonary disease was effective, and is worthy of popularization and application.
出处
《中医临床研究》
2018年第13期63-65,共3页
Clinical Journal Of Chinese Medicine
关键词
苏子降气汤
慢阻肺
急性加重期
中医中药
辨证施治
The Suzi Jiangqi decoction
Chronic obstructive pulmonary disease
Acute exacerbation
TCM medicine
Diferentiation